Back to Search Start Over

Identifying and managing patients at risk of severe allergic reactions to food: Report from two iFAAM workshops

Authors :
E. N. Clare Mills
Paul Turner
Andrew Clark
Audrey Dunn Galvin
Barbara K. Ballmer-Weber
Graham Roberts
Ronald van Ree
Ben Remington
Katie Allen
René W.R. Crevel
Sabine Schnadt
Jonathan O'b Hourihane
Kate Grimshaw
Lars K. Poulsen
Lynn Regent
Montserrat Fernandez-Rivas
Commission of the European Communities
Ear, Nose and Throat
Experimental Immunology
AII - Inflammatory diseases
APH - Global Health
APH - Personalized Medicine
Source :
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 12, 49, 1558-1566, Clinical and experimental allergy, 49(12), 1558-1566. Wiley-Blackwell
Publication Year :
2019

Abstract

Food allergy affects a small but important number of children and adults. Much of the morbidity associated with food allergy is driven by the fear of a severe reaction and fatalities continue to occur. Foods are the commonest cause of anaphylaxis. One of the aims of the European Union-funded Integrated Approaches to Food Allergen and Allergy Risk Management (iFAAM) project was to improve the identification and management of children and adults at risk of experiencing a severe reaction. A number of interconnected studies within the project have focused on quantifying the severity of allergic reactions; the impact of food matrix, immunological factors on severity of reactions; the impact of co-factors such as medications on the severity of reactions; utilizing single-dose challenges to understand threshold and severity of reactions; and community studies to understand the experience of patients suffering real-life allergic reactions to food. Associated studies have examined population thresholds and co-factors such as exercise and stress. This paper summarizes two workshops focused on the severity of allergic reactions to food. It outlines the related studies being undertaken in the project indicating how they are likely to impact on our ability to identify individuals at risk of severe reactions and improve their management. © 2019 John Wiley & Sons Ltd.

Details

Language :
English
ISSN :
09547894
Volume :
49
Issue :
12
Database :
OpenAIRE
Journal :
Clinical and experimental allergy
Accession number :
edsair.doi.dedup.....c3c1bb7fc457a31a8f1b014f0ac9d5a2